The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
NAGe5Q0MFf5U5JD8
